James W. McCollum, Director at LENZ Therapeutics, Inc. (LENZ), bought 10,500 shares at $22.79 ($239K) on 2025-11-07, disclosed to the SEC on 2025-11-10.
Open-market purchase of $239k LENZ by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.